Literature DB >> 26623044

Metachronous second primary lung cancer surgically treated five years or more after the initial surgery.

Satoshi Koezuka1, Yoshinobu Hata1, Hajime Otsuka1, Takashi Makino1, Naobumi Tochigi2, Kazutoshi Shibuya2, Akira Iyoda1.   

Abstract

Surgical treatment for metachronous second primary lung cancer following curative resection of primary lung cancer may be challenging. Standard surgical strategies for metachronous second primary lung cancer have not yet been established. The purpose of this study was to evaluate the outcomes of patients who underwent surgical resection for metachronous second primary lung cancer. A total of 12 patients surgically treated for metachronous second primary lung cancer ≥5 years after the initial surgery were retrospectively analyzed. The overall 5-year survival after the second surgery was 56.5%. There was no operative mortality. Patients with T1aN0M0 metachronous second primary lung cancer experienced a significantly higher 5-year overall survival rate compared with other patients (100 vs. 26.7%, respectively; P=0.0336). Among patients who underwent sublobar resection, all 3 patients with T1aN0M0 disease remained alive at the last follow-up, while 4 of the 5 patients (80%) with non-T1aN0M0 disease had developed recurrence. Surgery for metachronous second primary lung cancer may be safely performed. Early-stage metachronous second primary lung cancer was associated with a good prognosis, even among patients who underwent sublobar resection. Early detection of metachronous second primary lung cancer with close long-term follow-up following initial surgery may improve surgical outcomes.

Entities:  

Keywords:  lung cancer; metachronous second primary lung cancer; prognosis; recurrence; sublobar resection

Year:  2015        PMID: 26623044      PMCID: PMC4534874          DOI: 10.3892/mco.2015.594

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  16 in total

1.  Surgical treatment of metachronous nonsmall cell lung cancer.

Authors:  Shuji Haraguchi; Kiyoshi Koizumi; Tomomi Hirata; Kyoji Hirai; Iwao Mikami; Hirotoshi Kubokura; Yuki Nakajima; Kazuo Shimizu
Journal:  Ann Thorac Cardiovasc Surg       Date:  2010-10       Impact factor: 1.520

2.  Is lobectomy really more effective than sublobar resection in the surgical treatment of second primary lung cancer?

Authors:  Andrea Zuin; Luigi Gaetano Andriolo; Giuseppe Marulli; Marco Schiavon; Samuele Nicotra; Francesca Calabrese; Paola Romanello; Federico Rea
Journal:  Eur J Cardiothorac Surg       Date:  2013-05-08       Impact factor: 4.191

3.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

4.  Multiple primary lung cancers.

Authors:  N Martini; M R Melamed
Journal:  J Thorac Cardiovasc Surg       Date:  1975-10       Impact factor: 5.209

5.  Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer.

Authors:  Masatsugu Hamaji; Mark S Allen; Stephen D Cassivi; Claude Deschamps; Francis C Nichols; Dennis A Wigle; K Robert Shen
Journal:  J Thorac Cardiovasc Surg       Date:  2013-03       Impact factor: 5.209

6.  Surgery for second lung cancers.

Authors:  J W Asaph; J F Keppel; J R Handy; E C Douville; A C Tsen; G Y Ott
Journal:  Chest       Date:  2000-12       Impact factor: 9.410

Review 7.  Second lung cancers in patients successfully treated for lung cancer.

Authors:  B E Johnson; P Cortazar; J P Chute
Journal:  Semin Oncol       Date:  1997-08       Impact factor: 4.929

8.  Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition).

Authors:  Jeffrey Rubins; Michael Unger; Gene L Colice
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

9.  Benefits of resection for metachronous lung cancer.

Authors:  Richard J Battafarano; Seth D Force; Bryan F Meyers; Jennifer Bell; Tracey J Guthrie; Joel D Cooper; G Alexander Patterson
Journal:  J Thorac Cardiovasc Surg       Date:  2004-03       Impact factor: 5.209

Review 10.  Second lung cancers in patients after treatment for an initial lung cancer.

Authors:  B E Johnson
Journal:  J Natl Cancer Inst       Date:  1998-09-16       Impact factor: 13.506

View more
  2 in total

1.  Clinical outcomes of patients with metachronous second primary lung adenocarcinomas.

Authors:  Heng Zhao; Haitang Yang; Ke Han; Jianlin Xu; Feng Yao; Yang Zhao; Liwen Fan; Haiyong Gu; Zhenya Shen
Journal:  Onco Targets Ther       Date:  2017-01-10       Impact factor: 4.147

Review 2.  [Research Progress in Diagnosis and Management Strategies 
of Multiple Primary Lung Cancer].

Authors:  Haifa Guo; Yang Shen-Tu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.